Treating inflammatory diseases of the head and neck with cyclooxygenase-2 inhibitors
AssigneeCornell Research Foundation, Inc.
InventorAndrew J. Dannenberg
Life of this patent
Estimating the term…
Abstract
A patient with an inflammatory disease of the head and neck is treated with a therapeutic amount of a selective inhibitor of cyclooxygenase-2 or a cyclooxygenase-2 inhibitor from a natural source. In one embodiment, a patient with a sore throat caused by tonsillitis or pharyngitis is treated with the topical application of a cyclooxygenase-2 inhibitor from a natural source. In other embodiments, patients with sore throat caused by tonsillitis or pharyngitis or a patient with sinusitis are treated by systemic administration of a selective inhibitor of cyclooxygenase-2. In another embodiment, a patient with periodontitis is treated by administration of a cyclooxygenase-2 inhibitor from a natural source.
Claims17
A method for treating a patient with an inflammatory disease of the head and neck selected from the group consisting of sinusitis, periodontitis, and sore throat caused by tonsillitis or by pharyngitis, comprising a administering to said patient a therapeutic amount of a selective inhibitor of cyclooxygenase-2 or of a cyclooxygenase-2 inhibitor from natural source.
A method for treating a patient with a sore throat comprising administering to said patient a therapeutic amount of a cyclooxygenase-2 inhibitor from a natural source which is topically administered.
Dependencies are inferred from the claim text.